跳至主要内容
临床试验/NL-OMON34977
NL-OMON34977尚未招募2 期

Randomised, controlled, open label, cross-over trial to evaluate the tolerance of a new smoothie-style paediatric sip feed in children in need of oral nutritional support. - PAT-trial

Danone Research - Centre for Specialised Nutrition0 个研究点目标入组 19 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
19

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 至 17(—)

入选标准

  • - Male and female subjects, aged 3-12 years (including 3 and 12 years) in need of oral nutritional support (subject can be current or new paediatric sip feed user).
  • - Subject requires a paediatric sip feed for at least 6 weeks.
  • - Both hospitalized subjects and out-patients.
  • - Stable health status and expected to remain stable throughout the study (in the opinion of the Health Care Professional).
  • - Written informed consent from parents/guardian and subject (if applicable according to local law).

排除标准

  • - Cow*s milk allergy, known inflammatory bowel disease, bowel resection.
  • - Subjects requiring a fibre-free diet.
  • - Known allergy for fruit (apple, pear, strawberry, raspberry, banana, apricot, lemon) and/or carrot.
  • - Subjects requiring an adult rather than a paediatric sip feed.
  • - Major renal dysfunction (if requiring, but not yet receiving, dialysis).
  • - Major hepatic dysfunction (e.g. hepatitis, congenital abnormalities affecting the liver).
  • - Major gastrointestinal intolerance (e.g. vomiting, diarrhoea).
  • - Inherited metabolic disorders, including galactosaemia.
  • - Use of parenteral feeding and/or enteral tube-feeding.
  • - Investigator's uncertainty about the willingness or ability of the child/carer to comply with the protocol requirements.
  • - Participation in any other study involving investigational or marketed products concomitantly or within two weeks prior to entry into the study.

研究者

发起方
Danone Research - Centre for Specialised Nutrition

相似试验

进行中(未招募)
Unknown
A study to characterize nicotine delivery of the JUUL2 electronic nicotine delivery system as compared to a commercially available e-cigarette and combustible cigaretteicotine exposure
ISRCTN34837836JUUL Labs Inc28
招募中
1 期
Open label randomized, multicentre, controlled trial of pancreatic enzyme replacement therapy (PERT) for pancreatic exocrine insufficiency (PEI) in patients with unresectable pancreatic cancer.Pancreatic exocrine insufficiencyMedDRA version: 20.0Level: LLTClassification code: 10073392Term: Pancreatic exocrine insufficiency Class: 10017947
CTIS2023-507367-18-00Fundacion Instituto De Investigacion Sanitaria De Santiago De Compostela40
进行中(未招募)
不适用
An Open-label, Randomised, Three -Way, Cross-Over Study to Assess the Pharmacokinetics, Safety and Tolerability of Two Formulations of RBP-6300 10mg in Healthy Volunteers under a Naltrexone Block in the Presence and Absence of Food.Maintenance/substitution agent for the treatment of opioid dependence.MedDRA version: 16.0Level: LLTClassification code 10012346Term: Dependence on opiatesSystem Organ Class: 100000004873
EUCTR2012-002408-42-GBReckitt Benckiser Pharmaceuticals Inc.
已完成
不适用
A randomized, open-label, three-way crossover clinical trial to compare safety and pharmacokinetic characteristics after single administration of Carol-F Tab, Advil Liqui-Gels and Brufen Tab 200 mg in healthy male volunteersDiseases of the nervous system
KCT0002017Dong-A University Hospital36
招募中
不适用
Randomised, controlled, open label, cross-over trial to evaluate the tolerance of a new paediatric sip feed in children in need of oral nutritional support.Children in need of oral nutritional support
NL-OMON26666Danone Research – Centre for Specialised Nutrition28